BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 24068000)

  • 1. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease.
    Liu J; Ma KL; Zhang Y; Wu Y; Hu ZB; Lv LL; Tang RN; Liu H; Ruan XZ; Liu BC
    Int J Biochem Cell Biol; 2015 Apr; 61():8-19. PubMed ID: 25622557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mTOR contributes to foam cell formation in the radial arteries of patients with end-stage renal disease.
    Ma KL; Liu J; Gao M; Wang CX; Ni J; Zhang Y; Zhang XL; Liu H; Wang YL; Liu BC
    Clin Nephrol; 2014 Jun; 81(6):396-404. PubMed ID: 24755105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
    Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice.
    Xu ZE; Chen Y; Huang A; Varghese Z; Moorhead JF; Yan F; Powis SH; Li Q; Ruan XZ
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F713-22. PubMed ID: 21795641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation.
    Zhou C; Lei H; Chen Y; Liu Q; Li LC; Moorhead JF; Varghese Z; Ruan XZ
    PLoS One; 2013; 8(10):e75650. PubMed ID: 24146768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in LDL receptor feedback regulation in macrophages and vascular smooth muscle cells: foam cell transformation under inflammatory stress.
    Ye Q; Lei H; Fan Z; Zheng W; Zheng S
    Inflammation; 2014 Apr; 37(2):555-65. PubMed ID: 24297394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
    Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
    Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro.
    Yuan Y; Zhao L; Chen Y; Moorhead JF; Varghese Z; Powis SH; Minogue S; Sun Z; Ruan XZ
    Am J Physiol Renal Physiol; 2011 Jul; 301(1):F236-43. PubMed ID: 21511699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of failure of low density lipoprotein receptor expression induced by inflammation on radial artery foam cell formation in patients with end-stage renal disease].
    Ma KL; Liu J; Gao M; Ni J; Zhang Y; Zhang XL; Liu H; Huang HQ; Chen L; Wang YL; Liu BC
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):464-8. PubMed ID: 24059991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE
    Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo.
    Doyon P; van Zuylen WJ; Servant MJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2850-7. PubMed ID: 24135021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golgi a-mannosidase II mediates the formation of vascular smooth muscle foam cells under inflammatory stress.
    Zha K; Ye Q
    Folia Histochem Cytobiol; 2021; 59(2):134-143. PubMed ID: 34151999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines.
    Ruan XZ; Moorhead JF; Tao JL; Ma KL; Wheeler DC; Powis SH; Varghese Z
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1150-5. PubMed ID: 16543490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation.
    Li LC; Varghese Z; Moorhead JF; Lee CT; Chen JB; Ruan XZ
    Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H874-84. PubMed ID: 23335792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.
    Yeh M; Cole AL; Choi J; Liu Y; Tulchinsky D; Qiao JH; Fishbein MC; Dooley AN; Hovnanian T; Mouilleseaux K; Vora DK; Yang WP; Gargalovic P; Kirchgessner T; Shyy JY; Berliner JA
    Circ Res; 2004 Oct; 95(8):780-8. PubMed ID: 15388640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.